Erbb 2 receptor tyrosine breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Breast Cell Line, Tumor Tumor Cells, Cultured Cell Line MCF-7 Cells Mammary Glands, Human Cells, Cultured Axilla Epithelial Cells 3T3 Cells Neoplastic Stem Cells Nipples COS Cells Lymph Nodes Mammary Glands, Animal

Organisms4

Mice, Nude Mice, SCID Mice, Transgenic Mice, Inbred BALB C

Diseases33

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Mammary Neoplasms, Experimental Carcinoma, Lobular Lung Neoplasms Carcinoma Neoplasms Genetic Predisposition to Disease Carcinoma, Intraductal, Noninfiltrating Cell Transformation, Neoplastic Ovarian Neoplasms Neoplasms, Hormone-Dependent Lymphatic Metastasis Neoplasm Recurrence, Local Disease Progression Prostatic Neoplasms Fibrocystic Breast Disease Colonic Neoplasms Bone Neoplasms Adenocarcinoma Neovascularization, Pathologic Stomach Neoplasms Carcinoma, Ductal Pancreatic Neoplasms Carcinoma in Situ Inflammatory Breast Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms, Second Primary Triple Negative Breast Neoplasms

Chemicals and Drugs92

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Tyrosine Receptor Protein-Tyrosine Kinases Epidermal Growth Factor Receptors, Estrogen Tamoxifen Antineoplastic Agents Protein Tyrosine Phosphatases Receptors, Progesterone Tumor Markers, Biological Proto-Oncogene Proteins Oncogene Proteins v-erbB Neoplasm Proteins Antineoplastic Agents, Hormonal Quinazolines RNA, Messenger Protein Kinase Inhibitors Phosphotyrosine Receptor Tyrosine Kinase-like Orphan Receptors Tyrosine 3-Monooxygenase Proto-Oncogene Proteins c-met Estrogen Receptor alpha Estrogens RNA, Small Interfering Phosphatidylinositol 3-Kinases Antibodies, Monoclonal Enzyme Inhibitors Proto-Oncogene Proteins c-akt Adaptor Proteins, Signal Transducing Protein-Tyrosine Kinases Antibodies, Monoclonal, Humanized BRCA2 Protein BRCA1 Protein Estrogen Antagonists Aromatase Inhibitors Nitriles DNA, Neoplasm Ligands Phosphoproteins Receptor, EphA2 Proto-Oncogene Proteins c-kit Protein Tyrosine Phosphatase, Non-Receptor Type 11 Receptors, Eph Family Tyrphostins Estradiol Estrogen Receptor Modulators DNA-Binding Proteins Proteins Membrane Proteins Fluorouracil Recombinant Fusion Proteins Protein-Serine-Threonine Kinases Transcription Factors Receptor, EphB2 DNA Primers Pyrimidines Tumor Suppressor Proteins Recombinant Proteins Intracellular Signaling Peptides and Proteins Oncogene Proteins Tumor Suppressor Protein p53 Receptor, EphB4 Cyclophosphamide Proto-Oncogene Proteins c-ret Mitogen-Activated Protein Kinases Receptor, Insulin RNA, Neoplasm Indoles Intercellular Signaling Peptides and Proteins Receptor, EphA4 Epirubicin Selective Estrogen Receptor Modulators Protein Tyrosine Phosphatase, Non-Receptor Type 6 Paclitaxel Protein Tyrosine Phosphatase, Non-Receptor Type 1 Receptors, Cell Surface Ki-67 Antigen Genistein Receptors, Platelet-Derived Growth Factor GRB2 Adaptor Protein Receptors, Growth Factor ras Proteins Receptor, TIE-2 Protein Isoforms Proto-Oncogene Proteins pp60(c-src)Ephrin-A1 Antigens, Neoplasm Hepatocyte Growth Factor

Analytical, Diagnostic and Therapeutic Techniques and Equipment59

Mammography Prognosis Immunohistochemistry Neoplasm Staging Blotting, Western Early Detection of Cancer Mastectomy Mammary Neoplasms, Experimental Transfection Risk Factors Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Survival Analysis Xenograft Model Antitumor Assays Case-Control Studies Disease-Free Survival Breast Self-Examination Follow-Up Studies Survival Rate Risk Treatment Outcome Prospective Studies Transplantation, Heterologous Retrospective Studies Neoplasm Transplantation Risk Assessment Mastectomy, Segmental Odds Ratio Models, Biological Oligonucleotide Array Sequence Analysis Incidence Polymerase Chain Reaction Cohort Studies Molecular Targeted Therapy Tumor Burden Tissue Array Analysis Immunoblotting Multivariate Analysis Sensitivity and Specificity Registries Kaplan-Meier Estimate Immunoenzyme Techniques Ultrasonography, Mammary Drug Screening Assays, Antitumor Immunoprecipitation Gene Knockdown Techniques Predictive Value of Tests SEER Program Combined Modality Therapy In Situ Hybridization, Fluorescence Reproducibility of Results Questionnaires Logistic Models Clinical Trials as Topic Precipitin Tests Breast Implants DNA Mutational Analysis

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes50

Genes, erbB Signal Transduction Phosphorylation Gene Expression Regulation, Neoplastic Genes, erbB-2 Cell Proliferation Mutation Drug Resistance, Neoplasm Enzyme Activation Transfection Cell Division Genes, BRCA1 Cell Movement Postmenopause Amino Acid Sequence Apoptosis Genetic Predisposition to Disease Protein Binding Breast Feeding Down-Regulation Premenopause Base Sequence Time Factors Risk Menopause Cell Survival Genes, BRCA2 Gene Expression Dose-Response Relationship, Drug Gene Amplification Cell Growth Processes Odds Ratio Up-Regulation Protein Structure, Tertiary RNA Interference Promoter Regions, Genetic Cell Cycle Phenotype Sensitivity and Specificity Genotype src Homology Domains Binding Sites Germ-Line Mutation Cell Adhesion MAP Kinase Signaling System Polymorphism, Genetic Transcription, Genetic DNA Methylation Drug Synergism Gene Silencing

Disciplines and Occupations1

Immunohistochemistry

Information Science8

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate Incidence Registries SEER Program Questionnaires

Named Groups1

Health Care25

Risk Factors Survival Analysis Case-Control Studies Disease-Free Survival Follow-Up Studies Survival Rate Risk Treatment Outcome Prospective Studies Retrospective Studies Age Factors Risk Assessment Odds Ratio Incidence Cohort Studies Multivariate Analysis Sensitivity and Specificity Registries Kaplan-Meier Estimate Predictive Value of Tests SEER Program Reproducibility of Results Questionnaires Logistic Models Clinical Trials as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptor, erbB-2 Receptor, Epidermal Growth Factor Tyrosine Breast Genes, erbB Breast Neoplasms Receptor Protein-Tyrosine Kinases Epidermal Growth Factor Cell Line, Tumor Carcinoma, Ductal, Breast Signal Transduction Receptors, Estrogen Phosphorylation Gene Expression Regulation, Neoplastic Breast Diseases Tamoxifen Antineoplastic Agents Protein Tyrosine Phosphatases Receptors, Progesterone Neoplasm Metastasis Neoplasm Invasiveness Mammography Tumor Cells, Cultured Prognosis Tumor Markers, Biological Proto-Oncogene Proteins Genes, erbB-2 Cell Proliferation Oncogene Proteins v-erbB Mice, Nude Mutation Neoplasm Proteins Drug Resistance, Neoplasm Molecular Sequence Data Antineoplastic Agents, Hormonal Breast Neoplasms, Male Immunohistochemistry Quinazolines Neoplasm Staging RNA, Messenger Protein Kinase Inhibitors Blotting, Western Phosphotyrosine Early Detection of Cancer Enzyme Activation Receptor Tyrosine Kinase-like Orphan Receptors Mastectomy Mammary Neoplasms, Experimental Cell Line Transfection Risk Factors MCF-7 Cells Reverse Transcriptase Polymerase Chain Reaction Cell Division Genes, BRCA1 Cell Movement Postmenopause Carcinoma, Lobular Chemotherapy, Adjuvant Tyrosine 3-Monooxygenase Lung Neoplasms Carcinoma Neoplasms Antineoplastic Combined Chemotherapy Protocols Gene Expression Profiling Amino Acid Sequence Apoptosis Genetic Predisposition to Disease Carcinoma, Intraductal, Noninfiltrating Cell Transformation, Neoplastic Survival Analysis Xenograft Model Antitumor Assays Proto-Oncogene Proteins c-met Estrogen Receptor alpha Ovarian Neoplasms Estrogens Case-Control Studies RNA, Small Interfering Protein Binding Phosphatidylinositol 3-Kinases Breast Feeding Disease-Free Survival Down-Regulation Premenopause Neoplasms, Hormone-Dependent Base Sequence Time Factors Lymphatic Metastasis Mammary Glands, Human Antibodies, Monoclonal Breast Self-Examination Neoplasm Recurrence, Local Enzyme Inhibitors Disease Progression Follow-Up Studies Proto-Oncogene Proteins c-akt Survival Rate

No FAQ available that match "erbb 2 receptor tyrosine breast cancers receptor erbb 2"